{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T05:04:39Z","timestamp":1783400679442,"version":"3.54.6"},"reference-count":31,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.jceh.2022.04.016","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T12:11:54Z","timestamp":1650543114000},"page":"1293-1300","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Shani","family":"Feldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5921-3180","authenticated-orcid":false,"given":"Giancarlo","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Borrazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Madge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3173-9767","authenticated-orcid":false,"given":"Manuela","family":"Merli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2022.04.016_bib1","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jhep.2018.10.027","article-title":"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with\u00a0acute-on-chronic liver failure in Europe","volume":"70","author":"Fern\u00e1ndez","year":"2019","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib2","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2014.01.024","article-title":"Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013","volume":"60","author":"Jalan","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib3","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.jhep.2014.08.010","article-title":"Cirrhosis-associated immune dysfunction: distinctive features and clinical relevance","volume":"61","author":"Albillos","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jhep.2013.07.044","article-title":"Pathological bacterial translocation in liver cirrhosis","volume":"60","author":"Wiest","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/cld.169","article-title":"Bacterial infections in cirrhosis: a growing problem with significant implications","volume":"2","author":"Fernandez","year":"2013","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.jceh.2022.04.016_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127448","article-title":"The spread of multi drug resistant infections is leading to an increase in the empirical antibiotic treatment failure in cirrhosis: a prospective survey","volume":"10","author":"Merli","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.jceh.2022.04.016_bib7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1128\/CMR.05035-11","article-title":"Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions","volume":"25","author":"Tzouvelekis","year":"2012","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.jceh.2022.04.016_bib8","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1002\/eji.202048630","article-title":"Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the na\u00efve repertoire and are clonally expanded in the memory repertoire","volume":"51","author":"Cassotta","year":"2021","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.jceh.2022.04.016_bib9","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00883-17","article-title":"Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant Klebsiella pneumoniae bacteremia","volume":"61","author":"Shields","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jceh.2022.04.016_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/cid\/ciy492","article-title":"Efficacy of ceftazidime-avibactam salvage therapy in patients with infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae","volume":"68","author":"Tumbarello","year":"2019","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2022.04.016_bib11","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A\u00a0model to predict survival in patients with end-stage liver disease","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.016_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/gastro\/gox009","article-title":"Renal dysfunction in cirrhosis: acute kidney injury and the hepatorenal syndrome","volume":"5","author":"Bucsics","year":"2017","journal-title":"Gastroenterol Rep (Oxf)"},{"key":"10.1016\/j.jceh.2022.04.016_bib13","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1053\/j.gastro.2013.02.042","article-title":"Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis","volume":"144","author":"Moreau","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.04.016_bib14","series-title":"Annual Epidemiological Report on Communicable Diseases in Europe, 2014","year":"2014"},{"key":"10.1016\/j.jceh.2022.04.016_bib15","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s00134-017-4962-2","article-title":"When antibiotic treatment fails","volume":"44","author":"Bassetti","year":"2018","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jceh.2022.04.016_bib16","series-title":"EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical And\/or Epidemiological Importance","year":"2017"},{"key":"10.1016\/j.jceh.2022.04.016_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02562-17","article-title":"Comparison of septic shock due to multidrug-resistant acinetobacter baumannii or Klebsiella pneumoniae carbapenemase-producing K. pneumoniae in intensive care unit patients","volume":"62","author":"Russo","year":"2018","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jceh.2022.04.016_bib18","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1053\/j.gastro.2018.12.005","article-title":"Epidemiology and effects of bacterial infections in patients with cirrhosis worldwide","volume":"156","author":"Piano","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2022.04.016_bib19","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1016\/j.jfma.2021.04.014","article-title":"Healthcare-associated carbapenem-resistant Klebsiella pneumoniae bloodstream infections: risk factors, mortality, and antimicrobial susceptibility, 2017-2019","volume":"120","author":"Hsu","year":"2021","journal-title":"J\u00a0Formos Med Assoc"},{"key":"10.1016\/j.jceh.2022.04.016_bib20","doi-asserted-by":"crossref","first-page":"105833","DOI":"10.1016\/j.ijantimicag.2019.10.014","article-title":"A\u00a0systematic review and meta-analysis of treatment outcomes following antibiotic therapy among patients with carbapenem-resistant Klebsiella pneumoniae infections","volume":"55","author":"Agyeman","year":"2020","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jceh.2022.04.016_bib21","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1002\/hep.28332","article-title":"An empirical broad-spectrum antibiotic therapy in health-care-associated infections improves survival in patients with cirrhosis: a randomized trial","volume":"63","author":"Merli","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2022.04.016_bib22","doi-asserted-by":"crossref","first-page":"S227","DOI":"10.1016\/S0168-8278(14)60635-8","article-title":"Bacterial infections in cirrhotic patients: risk factors and rate of failure of the empirical antibiotic therapy","volume":"60","author":"Di Gregorio","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib23","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.clinre.2019.10.003","article-title":"Management of infections in patients with cirrhosis in the context of increasing therapeutic resistance: a systematic review","volume":"44","author":"Allaire","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jceh.2022.04.016_bib24","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1080\/14740338.2018.1488962","article-title":"Antimicrobial resistance and treatment: an unmet clinical safety need","volume":"17","author":"Bassetti","year":"2018","journal-title":"Expet Opin Drug Saf"},{"key":"10.1016\/j.jceh.2022.04.016_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/14787210.2018.1522249","article-title":"Multidrug-resistant Klebsiella pneumoniae: challenges for treatment, prevention and infection control","volume":"16","author":"Bassetti","year":"2018","journal-title":"Expert Rev Anti Infect Ther"},{"key":"10.1016\/j.jceh.2022.04.016_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/cid\/cix783","article-title":"Colistin versus ceftazidime-avibactam in the treatment of infections due to carbapenem-resistant enterobacteriaceae","volume":"66","author":"van Duin","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jceh.2022.04.016_bib27","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1097\/MEG.0b013e328355d8a2","article-title":"Spontaneous bacterial peritonitis due to carbapenemase-producing Klebsiella pneumoniae: the last therapeutic challenge","volume":"24","author":"Piano","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/liv.13195","article-title":"The impact of infection by multidrug-resistant agents in patients with cirrhosis. A multicenter prospective study","volume":"37","author":"Salerno","year":"2017","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2022.04.016_bib29","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2022.04.016_bib30","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1093\/jac\/dkw239","article-title":"Spotlight on ceftazidime\/avibactam: a new option for MDR Gram-negative infections","volume":"71","author":"Falcone","year":"2016","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jceh.2022.04.016_bib31","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1093\/cid\/ciaa586","article-title":"Efficacy of ceftazidime-avibactam plus Aztreonam in patients with bloodstream infections caused by metallo-\u03b2-lactamase-producing Enterobacterales","volume":"72","author":"Falcone","year":"2021","journal-title":"Clin Infect Dis"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688322001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:08:24Z","timestamp":1760854104000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688322001074"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S0973688322001074"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2022.04.016","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2022.04.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}